MARKER THERAPEUTICS, INC.: accounts_payable
| Value | {"amount": 680000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2016-12-31) |
| Status | current |
| Entity | MARKER THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T10:54:30.727303+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/fe55ebc0-72fb-4ca7-90ce-a29f167aa272
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001144204-18-016734Retrieved: 2026-08-19T10:54:30.727303+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001094038/accounts-payable/2016-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/fe55ebc0-72fb-4ca7-90ce-a29f167aa272
History
- supersedes {"amount": 680181, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} (evidence 0001144204-17-014490)